Published in Semin Arthritis Rheum on February 01, 1993
Sternocostoclavicular hyperostosis: a review. Ther Adv Musculoskelet Dis (2011) 0.98
Acquired hyperostosis syndrome--AHYS--(sternocostoclavicular hyperostosis, pustulotic arthro-osteitis, SAPHO-syndrome): bone scintigraphy of the anterior chest wall. Clin Rheumatol (1997) 0.89
Sternocostoclavicular Hyperostosis: An Insufficiently Recognized Clinical Entity. Clin Med Insights Arthritis Musculoskelet Disord (2017) 0.75
High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis: survey of a Dutch cohort. Orphanet J Rare Dis (2017) 0.75
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. Br J Clin Pharmacol (1980) 3.28
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Hypothesis: that rheumatoid arthritis will disappear. J Rheumatol (1979) 2.01
Judging "current disease activity" in rheumatoid arthritis--an international comparison. J Rheumatol (1983) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (1973) 1.80
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol (1986) 1.70
Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol (1989) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Cholesterol granuloma of the frontal sinus. J Laryngol Otol (2002) 1.68
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60
Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations. Br J Clin Pharmacol (1978) 1.59
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol (1992) 1.53
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Depression in rheumatoid arthritis. J R Coll Gen Pract (1977) 1.52
Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol (1979) 1.52
Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann Rheum Dis (1968) 1.47
Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol (1966) 1.43
Prior score availability: observations using the WOMAC osteoarthritis index. Br J Rheumatol (1991) 1.43
Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol (1973) 1.42
A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol (1990) 1.42
Septic arthritis complicating apatite associated destructive arthropathy. Ann Rheum Dis (1990) 1.41
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol (1991) 1.40
Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol (1994) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
Are gallstones less prevalent in rheumatoid arthritis? Clin Rheumatol (1991) 1.39
Is diet important in rheumatoid arthritis? Br J Rheumatol (1991) 1.39
Evidence based medicine: the median is not the message. J Rheumatol (2001) 1.38
Benefits of hospitalization in rheumatoid arthritis. Q J Med (1974) 1.37
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol (1983) 1.35
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol (1976) 1.31
Auranofin. Br J Rheumatol (1997) 1.30
Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent. Ann Rheum Dis (1972) 1.28
Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.28
Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. Q J Med (1967) 1.25
Arylsulfatase in Salmonella typhimurium: detection and influence of carbon source and tyramine on its synthesis. J Bacteriol (1979) 1.23
Validation of cocaine and marijuana effect expectancies in a treatment setting. Addict Behav (1999) 1.22
Generalised and localised bone loss in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.21
Association of Thyrotoxicosis and Auto-immune Thyroiditis. Br Med J (1961) 1.20
How safe are anti-rheumatic drugs? A study of possible iatrogenic deaths in patients with rheumatoid arthritis. Health Bull (Edinb) (1975) 1.19
Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child (1992) 1.19
Distribution of certain autoantibodies in monozygotic and dizygotic twins. Ann Rheum Dis (1966) 1.17
Outcome measurement in osteoarthritis clinical trials: the case for standardisation. Clin Rheumatol (1984) 1.17
Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1987) 1.16
Poor quality of posts in clinical rheumatology: a cause of failure to advance the specialty. Br Med J (1976) 1.15
Radioisotope study of small joint inflammation in rheumatoid arthritis. Ann Rheum Dis (1971) 1.15
Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis. J Rheumatol (1984) 1.15
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Penetration of sodium fusidate (Fucidin) in the synovial cavity. Scand J Rheumatol (1972) 1.13
Antirheumatic drugs: clinical pharmacology and therapeutic use. Drugs (1980) 1.12
Pulmonary involvement in systemic lupus erythematosus. Ann Rheum Dis (1978) 1.11
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance technique. Clin Sci (1971) 1.10
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.10
Serum uric acid in England and Scotland. Ann Rheum Dis (1977) 1.10
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index. J Rheumatol (1994) 1.10
Pulmonary infection and rheumatoid arthritis. Br J Dis Chest (1978) 1.10
A comparative study of some commercially available tests for rheumatoid factor. J Clin Pathol (1974) 1.09
Relative roles of genetic and environmental factors in the control of serum uric acid levels in normouricaemic subjects. Ann Rheum Dis (1967) 1.08
Plasma immunoglobulin concentrations in twins. Clin Exp Immunol (1968) 1.07
NSAID and osteoarthritis--help or hindrance? J Rheumatol (1982) 1.07
Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. J Rheumatol (1976) 1.06
Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology (2004) 1.06
Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorgan-specific autoimmune diseases. Ann Rheum Dis (1978) 1.05
Observations on drug prescribing in rheumatoid arthritis. Br Med J (1974) 1.05
Bone loss in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.05
Plasma creatinine rises dramatically in the first 48 hours of life in preterm infants. Pediatrics (1999) 1.05
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol (1991) 1.04
Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis (2002) 1.04
Indomethacin--aspirin interaction: a clinical appraisal. Br Med J (1975) 1.04
Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy. Ann Rheum Dis (1968) 1.03
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br J Cancer (2008) 1.02
The detection of spinal pseudarthrosis in ankylosing spondylitis. Br J Radiol (1981) 1.01
Bone-resorbing activity in the sera of patients with rheumatoid arthritis. Clin Sci Mol Med (1976) 1.00
Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis (1991) 1.00
Clinical evaluation of two strategies for improving patient recall of prior drug therapy. Br J Clin Pharmacol (1984) 1.00
Personal points of view--the need for expansion of medical social work facilities and personnel in rheumatology. Health Bull (Edinb) (1974) 1.00
Alcohol expectancies and motives in a substance abusing male treatment sample. Drug Alcohol Depend (2001) 1.00
Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann Rheum Dis (1970) 0.99
Inheritance of ankylosing spondylitis and HL-A antigen W27. Lancet (1974) 0.98
Methods of assessment used in ankylosing spondylitis clinical trials: a review. Br J Rheumatol (1991) 0.98
The economics of arthritis. Bull Rheum Dis (1973) 0.98
Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis (2006) 0.97
Interactions of anti-rheumatic drugs. Agents Actions Suppl (1977) 0.97